Opening Session: Part I	10
Opening Session: Part II	11
IBD: New drugs, new risks	12
Therapeutic nutrition in IBD	16
Modern management of oesophageal dysmotility: Can we do better?	17
IBD: Basic science	19
Basic science: Neurogastroenterology	22
Hot topics from Latin America	24
Gastric intestinal metaplasia: The premalignant stomach	25
Clinical update on H.pylori management	26
Pancreatic neoplasms: Improving diagnosis and outcomes	27
Endoscopy: The heat in diagnosis and therapy	30
Towards microbiome targeted therapies	35
Epidemiology and treatment of IBD	38
Clinical perspectives on H. pylori infection	42
Hepatology from bench to bedside	45
Update in cholangiocarcinoma	47
Brave new world: Neurons vs. neuronal network	48
Barrett›s oesophagus	51
What›s hot in eosinophilic oesophagitis	52
Pathogenesis of H. pylori infection	55
IBD: Health care and patient-reported outcomes	58
Management of patients with portal hypertension	61
Expanding the horizons for early colonic cancer	62
Perianal fistula in Crohn›s disease	65
Shifting paradigms in oesophageal cancer management	66

Tuesday, 22 October 2019

Different faces of microbiota along the digestive tract	69
Primum non nocere: Making ERCP safer	72
New impulses in management of gastroparesis	75
Advances in endoscopy and faecal testing for IBD and cancer	78
Randomised controlled trials in IBD I	81
Optimising treatment strategies in pancreatitis and pancreatic cancer	85
Novel therapeutic approaches in microscopic colitis and c. difficile	87
Randomised controlled trials in IBD II	90
Make the gallbladder great again	94
Basic science: The intestinal epithelium and IBD	96
Colonic ESD: Does size matter?	98
Lower Gl diseases 4.0: Integrating modern approaches into daily practice	102
Holistic management of IBD patients	103
Tackling the NAFLD/NASH epidemics	106
IBS treatment	107
Lower Gl on fire	111
Paradigm shifts in IBD treatment	116
Frontiers in pancreatic neoplasia	119
IBD: Basic Science I	122
How to improve the diagnosis of GORD	125
Big data to robotics	128
Evidence-based improvements in surgical outcomes	129
Duodenal flat mucosa: Coeliac and beyond	131
Trends in treatment and detection of upper Gl bleeding	132
Cirrhosis and liver cancer	135
Intestinal epithelium in health and disease	138
Improving colorectal cancer screening	141
New ways to predict response in IBD	144
New frontiers in pancreatic neoplasias	146
Bile duct stone management	147
Risk assessment, diagnosis and management in colon cancer	148
HPB on fire	150

Wednesday, 23 October 2019

What's hot in cold snaring	155
What causes (recurrent) acute pancreatitis?	157
From bench to bedside in pancreatic cancer	160
Towards early diagnosis of gastric cancer	163
Biomarker-based classification of IBD	165
Highlights in oesophageal cancer: What's hot?	168
An integrated view of microbiome in IBD	171
Seeing is believing: Improving polyp detection	173
Enteropathies: From bench to bedside	176
Video Case Session	178
Oncology: Basic mechanisms	182
Hot topics in gastric cancer	184

Liver and Biliary I	190
Pancreas I	223
Endoscopy and Imaging I	239
Surgery I	300
IBD I	306
Other Lower Gl Disorders I	373
Paediatric: Lower Gl I	404
Oesophageal, Gastric and Duodenal Disorders I	405
H. Pylori I	443
Small Intestinal I	449
Nutrition I	457
Paediatric: Upper Gl I	462

Liver & Biliary II	465
Pancreas II	500
Endoscopy and Imaging II	516
Surgery II	577
IBD II	584
Other Lower Gl Disorders II	647
Paediatric: Lower Gl II	682
Oesophageal, Gastric and Duodenal Disorders II	685
H. Pylori II	728
Small Intestinal II	735
Nutrition II	743
Women in Gl	748
Paediatric: Upper Gl II	749

Liver and Biliary III	752
Pancreas III	785
Paediatric: Liver, Biliary and Pancreas	801
Endoscopy and Imaging III	804
Surgery III	862
Paediatric: Endocsopy, Imaging and Surgery	867
IBD III	868
Other Lower Gl Disorders III	926
Paediatric: Lower Gl III	960
Oesophageal, Gastric and Duodenal Disorders III	962
H. Pylori III	1005
Small Intestinal III	1013
Nutrition III	1023
Paediatric: Upper Gl III	1028
Author Index	1031